A comparative study of safety and efficacy of bilastine updosing (40mg) vs combination of bilastine 20mg with levocetrizine 5mg in the treatment of chronic spontaneous urticaria
Not Applicable
- Conditions
- Health Condition 1: L49-L54- Urticaria and erythema
- Registration Number
- CTRI/2022/10/046449
- Lead Sponsor
- SRM Medical college hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients previously treated with bilastine 20mg for 2 weeks but developing new lesions
Exclusion Criteria
Hereditary angioedema
Food or drug allergy
Collagen vascular diseases
Atopic dermatitis
Systemic autoimmune disorders
Hodgkinââ?¬•s disease
Pregnant and lactating women
Patients on systemic or topical corticosteroids within 4 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method